In the past week, ALHC stock has gone up by 8.14%, with a monthly gain of 35.78% and a quarterly surge of 34.28%. The volatility ratio for the week is 4.66%, and the volatility levels for the last 30 days are 5.32% for Alignment Healthcare Inc The simple moving average for the last 20 days is 19.03% for ALHC’s stock, with a simple moving average of 52.58% for the last 200 days.
Is It Worth Investing in Alignment Healthcare Inc (NASDAQ: ALHC) Right Now?
The stock has a 36-month beta value of 1.50. Opinions on the stock are mixed, with 8 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for ALHC is 92.24M, and at present, short sellers hold a 10.38% of that float. On January 23, 2025, the average trading volume of ALHC was 1.90M shares.
ALHC) stock’s latest price update
Alignment Healthcare Inc (NASDAQ: ALHC)’s stock price has soared by 0.27 in relation to previous closing price of 14.57. Nevertheless, the company has seen a gain of 8.14% in its stock price over the last five trading days. seekingalpha.com reported 2025-01-16 that Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-side analyst forecasts. Coming off a challenging end to 2024, the upcoming earnings season is an opportunity for managed care companies to focus on 2025 expectations and Medicare Advantage growth, according to J.P. Morgan analyst Lisa Gill. UnitedHealth and Oscar Health are expected to log sequential and year-over-year revenue growth.
Analysts’ Opinion of ALHC
Many brokerage firms have already submitted their reports for ALHC stocks, with Stephens repeating the rating for ALHC by listing it as a “Overweight.” The predicted price for ALHC in the upcoming period, according to Stephens is $17 based on the research report published on December 03, 2024 of the previous year 2024.
BofA Securities gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on May 30th of the previous year.
ALHC Trading at 20.34% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.79% of loss for the given period.
Volatility was left at 5.32%, however, over the last 30 days, the volatility rate increased by 4.66%, as shares surge +42.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.25% upper at present.
During the last 5 trading sessions, ALHC rose by +8.14%, which changed the moving average for the period of 200-days by +210.85% in comparison to the 20-day moving average, which settled at $12.27. In addition, Alignment Healthcare Inc saw 29.87% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from HAKAN KARDES, who proposed sale 25,000 shares at the price of $14.58 back on Jan 21 ’25. After this action, HAKAN KARDES now owns shares of Alignment Healthcare Inc, valued at $364,500 using the latest closing price.
Maroney Dawn Christine, the President of Alignment Healthcare Inc, sale 30,000 shares at $13.61 during a trade that took place back on Jan 15 ’25, which means that Maroney Dawn Christine is holding 1,606,097 shares at $408,384 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.1 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.06. The total capital return value is set at -0.36. Equity return is now at value -95.13, with -19.71 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.66 points at debt to capital in total, while cash flow to debt ratio is standing at -0.65. The debt to equity ratio resting at 1.92. The interest coverage ratio of the stock is -5.14.
Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 1.27. When we switch over and look at the enterprise to sales, we see a ratio of 1.09. The receivables turnover for the company is 17.77for trailing twelve months and the total asset turnover is 3.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.
Conclusion
To sum up, Alignment Healthcare Inc (ALHC) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
